Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details) - Schedule of segment reporting information

v3.21.1
Segment Information (Details) - Schedule of segment reporting information - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Segment Reporting Information [Line Items]    
Other operating expenses $ 2,376,468 $ 3,264,647
Interest expense (45,149) (42,169)
Other income (expense) (18,381) (6,420)
Total other expense, net (63,530) (48,589)
Net income (loss) (2,367,118) (3,270,781)
Real property operations [Member]    
Segment Reporting Information [Line Items]    
Revenues 289,774 296,956
Costs and expenses 216,894 254,501
Gross profit (loss) 72,880 42,455
Other operating expenses 101,423 110,816
Other income (expense) 104 (935)
Net income (loss) 28,439 69,296
Medical related consulting services - related party [Member]    
Segment Reporting Information [Line Items]    
Other operating expenses 161,553 155,235
Other income (expense) (18,486) (5,487)
Net income (loss) 180,039 160,722
Development services and sales of developed products [Member]    
Segment Reporting Information [Line Items]    
Other operating expenses 35,999
Other income (expense) 2
Net income (loss) 35,997
Corporate/Other [Member]    
Segment Reporting Information [Line Items]    
Other operating expenses 2,113,492 2,962,597
Interest expense (45,149) (42,169)
Other income (expense) 1
Net income (loss) $ 2,158,640 $ 3,004,766